Matthew M Hamill, MBChB, MPH, MSc, PhD
Disclosures: Consulting Fee-Roche|Consulting Fee-GlaxoSmithKline|Royalties or Patent Beneficiary-UpToDate|Honoraria-Clinical Care Options (Relationship has ended)|Royalties or Patent Beneficiary-BMJ - 06/10/2022
No Bio Available.